▲ 1.90%
prev close
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Congressional Trades
13
All tracked trades
Members Trading
5
Unique members
Net Activity
+1
7 buys · 6 sells
Members Who Traded This Stock
13 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-09-10 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 25d ago | — | |
| 2026-08-31 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 25d ago | — | |
| 2026-08-26 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 33d ago | — | |
| 2025-10-31 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 333d ago | — | |
| 2025-10-30 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 333d ago | — | |
| 2025-09-11 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 363d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 432d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Buy | $15,001 - $50,000 | 432d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 403d ago | — | |
| 2025-06-09 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 433d ago | — | |
| 2025-03-27 | NVONovo Nordisk A/S Common Stock | Buy | $15,001 - $50,000 | 557d ago | — | |
| 2024-10-29 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 403d ago | — | |
| 2023-07-12 | NVONovo Nordisk A/S Common Stock | Sell | $100,001 - | 1164d ago | — |
2026-09-10
Kevin Hern
NVO
Amount
$1,001 - $15,000
Filed
25d ago
2026-08-31
Kevin Hern
NVO
Amount
$1,001 - $15,000
Filed
25d ago
2026-08-26
Scott Scott Franklin
NVO
Amount
$1,001 - $15,000
Filed
33d ago
2025-10-31
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
333d ago
2025-10-30
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
333d ago
2025-09-11
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
363d ago
2025-08-04
Scott Scott Franklin
NVO
Amount
$1,001 - $15,000
Filed
432d ago
2025-08-04
Scott Scott Franklin
NVO
Amount
$15,001 - $50,000
Filed
432d ago
2025-08-04
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
403d ago
2025-06-09
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
433d ago
2025-03-27
Scott Scott Franklin
NVO
Amount
$15,001 - $50,000
Filed
557d ago
2024-10-29
Valerie Hoyle
NVO
Amount
$1,001 - $15,000
Filed
403d ago
2023-07-12
Daniel Goldman
NVO
Amount
$100,001 -
Filed
1164d ago
Recent News
Powered by Polygon.io
Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market
How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?
Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter.
Trade Timeline
Congressional activity, newest first
Kevin Hern
2026-09-10 · Sale
$1,001 - $15,000
Kevin Hern
2026-08-31 · Sale
$1,001 - $15,000
Scott Scott Franklin
2026-08-26 · Purchase
$1,001 - $15,000
Lisa McClain
2025-10-31 · Sale
$1,001 - $15,000
Lisa McClain
2025-10-30 · Sale
$1,001 - $15,000
Lisa McClain
2025-09-11 · Purchase
$1,001 - $15,000
Scott Scott Franklin
2025-08-04 · Purchase
$1,001 - $15,000
Scott Scott Franklin
2025-08-04 · Purchase
$15,001 - $50,000
Lisa McClain
2025-08-04 · Sale
$1,001 - $15,000
Lisa McClain
2025-06-09 · Purchase
$1,001 - $15,000
Scott Scott Franklin
2025-03-27 · Purchase
$15,001 - $50,000
Valerie Hoyle
2024-10-29 · Purchase
$1,001 - $15,000
Daniel Goldman
2023-07-12 · Sale
$100,001 -